- Home
- HCAT vs EBS Comparison
HCAT vs EBS Comparison
Compare HCAT & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCAT
- EBS
- Stock Information
- Founded
- HCAT 2008
- EBS 1998
- Country
- HCAT United States
- EBS United States
- Employees
- HCAT N/A
- EBS N/A
- Industry
- HCAT Computer Software: Programming Data Processing
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- HCAT Technology
- EBS Health Care
- Exchange
- HCAT Nasdaq
- EBS Nasdaq
- Market Cap
- HCAT 464.4M
- EBS 459.6M
- IPO Year
- HCAT 2019
- EBS 2006
- Fundamental
- Price
- HCAT $7.09
- EBS $8.09
- Analyst Decision
- HCAT Buy
- EBS Strong Buy
- Analyst Count
- HCAT 11
- EBS 2
- Target Price
- HCAT $11.75
- EBS $14.00
- AVG Volume (30 Days)
- HCAT 588.2K
- EBS 1.0M
- Earning Date
- HCAT 11-06-2024
- EBS 11-06-2024
- Dividend Yield
- HCAT N/A
- EBS N/A
- EPS Growth
- HCAT N/A
- EBS N/A
- EPS
- HCAT N/A
- EBS N/A
- Revenue
- HCAT $302,062,000.00
- EBS $1,125,500,000.00
- Revenue This Year
- HCAT $6.04
- EBS $6.64
- Revenue Next Year
- HCAT $11.19
- EBS $7.95
- P/E Ratio
- HCAT N/A
- EBS N/A
- Revenue Growth
- HCAT 4.15
- EBS 2.05
- 52 Week Low
- HCAT $5.42
- EBS $1.42
- 52 Week High
- HCAT $11.41
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- HCAT 35.24
- EBS 39.08
- Support Level
- HCAT $7.75
- EBS $8.35
- Resistance Level
- HCAT $8.00
- EBS $8.86
- Average True Range (ATR)
- HCAT 0.52
- EBS 0.50
- MACD
- HCAT -0.15
- EBS -0.11
- Stochastic Oscillator
- HCAT 15.74
- EBS 17.58
About HCAT Health Catalyst Inc
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.